- January 15, 2019
- Posted by: eric
- Category: Optio company news, Uncategorized
JPM, January 2019, San Francisco. In addition to attending JPM meetings with a focus on rare disease, Optio conducted asset valuation work on behalf of a client. Discussions with a potential out-licensing partner were held to reach an understanding on market assumptions. Optio provided due diligence through interviews with relevant thought leaders combined with expert opinion on valuation and commercial risk.